Clearance Summary
PREVENA 125 and PREVENA PLUS 125 Therapy Units received FDA 510(k) clearance under submission number DEN180013, sponsored by Kci USA, Inc.. The device was reviewed via the Direct premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2019-04-19.
- Submission: DEN180013
- Applicant / Sponsor: Kci USA, Inc.
- Clearance pathway: Direct
- Review panel: General, Plastic Surgery
- Device class: Class II
- Regulation citation: 21 CFR 878.4783
- Decision date: 2019-04-19
Classification & Regulation
This clearance is catalogued under FDA product code QFC and 21 CFR 878.4783, within the General, Plastic Surgery review panel as a Class II device.